Konrad Herbst
Overview
Explore the profile of Konrad Herbst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
515
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Herbst K, Wang T, Forchielli E, Thommes M, Paschalidis I, Segre D
Commun Biol
. 2024 Apr;
7(1):407.
PMID: 38570615
The interpretation of complex biological datasets requires the identification of representative variables that describe the data without critical information loss. This is particularly important in the analysis of large phenotypic...
2.
Deckert A, Anders S, Morales I, De Allegri M, Nguyen H, Souares A, et al.
JMIR Public Health Surveill
. 2024 Feb;
10:e57203.
PMID: 38364221
[This corrects the article DOI: 10.2196/44204.].
3.
Deckert A, Anders S, Morales I, De Allegri M, Nguyen H, Souares A, et al.
JMIR Public Health Surveill
. 2023 May;
9:e44204.
PMID: 37235704
Background: The COVID-19 pandemic is characterized by rapid increases in infection burden owing to the emergence of new variants with higher transmissibility and immune escape. To date, monitoring the COVID-19...
4.
Lou D, Meurer M, Ovchinnikova S, Burk R, Denzler A, Herbst K, et al.
EMBO Rep
. 2023 Mar;
24(5):e57162.
PMID: 36951170
Throughout the SARS-CoV-2 pandemic, limited diagnostic capacities prevented sentinel testing, demonstrating the need for novel testing infrastructures. Here, we describe the setup of a cost-effective platform that can be employed...
5.
Deckert A, Anders S, De Allegri M, Nguyen H, Souares A, McMahon S, et al.
Trials
. 2021 Sep;
22(1):656.
PMID: 34565421
Background: To achieve higher effectiveness in population-based SARS-CoV-2 surveillance and to reliably predict the course of an outbreak, screening, and monitoring of infected individuals without major symptoms (about 40% of...
6.
Herbst K, Meurer M, Kirrmaier D, Anders S, Knop M, Dao Thi V
Bio Protoc
. 2021 Apr;
11(6):e3964.
PMID: 33855122
During pandemics, such as the one caused by SARS-CoV-2 coronavirus, simple methods to rapidly test large numbers of people are needed. As a faster and less resource-demanding alternative to detect...
7.
Deckert A, Anders S, De Allegri M, Nguyen H, Souares A, McMahon S, et al.
Trials
. 2021 Jan;
22(1):39.
PMID: 33419461
Objectives: In this cluster-randomised controlled study (CoV-Surv Study), four different "active" SARS-CoV-2 testing strategies for general population surveillance are evaluated for their effectiveness in determining and predicting the prevalence of...
8.
Stefl M, Herbst K, Rubsam M, Benda A, Knop M
Biophys J
. 2020 Sep;
119(7):1359-1370.
PMID: 32919495
The ability to quantify protein concentrations and to measure protein interactions in vivo is key information needed for the understanding of complex processes inside cells, but the acquisition of such...
9.
Dao Thi V, Herbst K, Boerner K, Meurer M, Kremer L, Kirrmaier D, et al.
Sci Transl Med
. 2020 Jul;
12(556).
PMID: 32719001
The coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) coronavirus is a major public health challenge. Rapid tests for detecting existing SARS-CoV-2 infections...
10.
Fueller J, Herbst K, Meurer M, Gubicza K, Kurtulmus B, Knopf J, et al.
J Cell Biol
. 2020 May;
219(6).
PMID: 32406907
Here we describe a time-efficient strategy for endogenous C-terminal gene tagging in mammalian tissue culture cells. An online platform is used to design two long gene-specific oligonucleotides for PCR with...